231 related articles for article (PubMed ID: 18245644)
1. Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia.
Castagnola C; Elena C; Merli M
Haematologica; 2008 Feb; 93(2):e28. PubMed ID: 18245644
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system involvement at the time of presentation in acute promyelocytic leukemia.
Collins C; Knoderer H
Pediatr Blood Cancer; 2010 Apr; 54(4):603-5. PubMed ID: 19998465
[TBL] [Abstract][Full Text] [Related]
3. [Central nervous system relapse with multiple brain masses in an acute promyelocytic leukemia patient treated with all-trans retinoic acid].
Maeda A; Kobayashi Y; Saito T; Togitani K; Kawahigashi N; Tanosaki R; Takaue Y; Takenaka T; Iwata N; Tobinai K
Rinsho Ketsueki; 1999 Oct; 40(10):1081-6. PubMed ID: 10565225
[TBL] [Abstract][Full Text] [Related]
4. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
Dalal BI; Bruyere H; Barnett MJ
Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
[No Abstract] [Full Text] [Related]
5. Central nervous system relapse in acute promyelocytic leukemia.
Colovic N; Bogdanovic A; Miljic P; Jankovic G; Colovic M
Am J Hematol; 2002 Sep; 71(1):60-1. PubMed ID: 12221680
[No Abstract] [Full Text] [Related]
6. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?
Mallo M; Salido M; Espinet B; Cervera J; Canellas A; Pajuelo JC; Pedro C; Florensa L; Sanz MA; Solé F
Leuk Res; 2007 Sep; 31(9):1315-7. PubMed ID: 17092559
[No Abstract] [Full Text] [Related]
7. [Isolated relapse in the central nervous system during cytologic and hematologic remission in a patient with acute promyelocytic leukemia].
Vivanco-Hidalgo RM; Gimeno E; Gálvez A; Rodríguez-Campello A
Neurologia; 2010 Apr; 25(3):200-1. PubMed ID: 20492869
[No Abstract] [Full Text] [Related]
8. Central nervous system relapse in CD56+, FLT3/ITD+ promyelocytic leukemia.
Colovic N; Tomin D; Vidovic A; Tosic N; Atkinson HD; Colovic MD
Med Oncol; 2012 Mar; 29(1):260-2. PubMed ID: 21298367
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system relapse in a patient with acute promyelocytic leukaemia: does the risk stratification matter?
Sahin DG; Gunduz E; Akay OM; Gulbas Z
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23749823
[TBL] [Abstract][Full Text] [Related]
10. Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases.
Ferrara F; Selleri C; Mele G; Serio B; Palmieri S; Pocali B; Pane F; Rotoli B
Ann Hematol; 2004 Jul; 83(7):484-6. PubMed ID: 14730393
[TBL] [Abstract][Full Text] [Related]
11. Isolated central nervous system relapse in childhood acute promyelocytic leukemia.
Scheinemann K; Weitzman S; Hitzler J; Doyle J; Abla O
J Pediatr Hematol Oncol; 2008 Feb; 30(2):160-2. PubMed ID: 18376270
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system acute promyelocytic leukaemia: a report of three cases.
Marra R; Stori S; Pagano L; Fioritoni G; Rabitti C; Sica S; Leone G; Torlontano G; Bizzi B
Haematologia (Budap); 1989; 22(3):195-9. PubMed ID: 2583600
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
Lo Coco F; Diverio D; Avvisati G; Mandelli F
Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
[No Abstract] [Full Text] [Related]
14. Central nervous system relapse in acute promyelocytic leukaemia treated with all-trans retinoic acid.
Seldon M; Enno A
Aust N Z J Med; 1998 Aug; 28(4):462. PubMed ID: 9777115
[No Abstract] [Full Text] [Related]
15. The significance of minimal residual disease kinetics in adults with newly diagnosed PML-RARalpha-positive acute promyelocytic leukemia: results of a prospective trial.
Lee S; Kim YJ; Eom KS; Min CK; Kim HJ; Cho SG; Lee JW; Min WS; Kim CC
Haematologica; 2006 May; 91(5):671-4. PubMed ID: 16627255
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system involvement at second relapse in acute promyelocytic leukemia treated with ATRA and chemotherapy.
Kumar B; Sharma V; Chopra A; Mahapatra M; Kumar R; Mathur S; Sazawal S; Kumar S; Saxena R
Leuk Res; 2010 Oct; 34(10):e264-5. PubMed ID: 20537387
[No Abstract] [Full Text] [Related]
17. Isolated central nervous system relapse of acute promyelocytic leukemia with altered morphology in an asymptomatic patient.
Sardana R; Balakrishna JP
Blood Cells Mol Dis; 2021 Dec; 92():102616. PubMed ID: 34634584
[No Abstract] [Full Text] [Related]
18. FLT3 internal tandem duplication is associated with a high relapse rate and central nervous system involvement in acute promyelocytic leukemia cases: single institutional analysis.
Tashiro H; Shirasaki R; Oka Y; Sugao T; Mizutani-Noguchi M; Yamamoto T; Akiyama N; Kawasugi K; Shirafuji N
Eur J Haematol; 2011 Mar; 86(3):272-3. PubMed ID: 21129033
[No Abstract] [Full Text] [Related]
19. Rapid response to induction in a case of acute promyelocytic leukemia with MYC amplification on double minutes at diagnosis.
Zuberi L; Adeyinka A; Kuriakose P
Cancer Genet Cytogenet; 2010 Apr; 198(2):170-2. PubMed ID: 20362234
[No Abstract] [Full Text] [Related]
20. Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy.
Dvorak CC; Sanders RP; Dahl GV; Donaldson SS; Razzouk BI
Pediatr Blood Cancer; 2007 May; 48(5):582-5. PubMed ID: 16123994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
